Android 17 Beta 1 is rolling out to Google Google Pixel 6 and newer devices. If you are on Android 16 beta, update via Settings > System > Software Update. Stable ...
TV and home video editor Ty Pendlebury joined CNET Australia in 2006, and moved to New York City to be a part of CNET in 2011. He tests, reviews and writes about the latest TVs and audio equipment.
Given the continuous Android Canary channel, the next major version of Google’s mobile OS is debuting as a Beta release. Android 17 Beta 1 is rolling out today to Pixel devices. Android Canary was ...
You might have noticed some reporting a few days ago that Android 17 was rolling out in beta form, but that didn’t happen. For reasons Google still has not explained, the release was canceled. Two ...
Arcus Biosciences is a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for the treatment of cancer and inflammatory and autoimmune diseases. In ...
Google has confirmed that Android’s Quick Share-AirDrop interoperability is expanding beyond the Pixel 10 series to more Android devices this year. The company says it’s working with partners to ...
Last summer, Google announced that Android 16 would include a desktop interface built from Samsung DeX, a mirroring and phone integration tool for PC. Thanks to a (now permissions-restricted) bug ...
From swirling updates to confusing convergence and more than a few wacky experiments, 2026 is looking to be anything but uneventful for Google's Android platform. It’s hard to believe, but here we be ...
82,997 shares were sold indirectly on Dec. 4, 2025, for a transaction value of ~$2.1 million based on a weighted average sale price of $24.71 per share. The sale represented 5.91% of total holdings, ...
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...
Rahul Naskar has years of experience writing news and features related to Android, phones, and apps. Outside the tech world, he follows global events and developments shaping the world of geopolitics.